Short Sellers Can’t Make Up Their Minds on Major Oil
After the election was decided this week with the Republican candidate taking the White House, short interest for these major oil stocks is now more important than ever to follow.
All Work
Chris Lange
Mylan Rises on Mixed Earnings
Mylan N.V. (NASDAQ: MYL) released third-quarter earnings after markets closed on Wednesday. The company posted $1.38 in earnings per share (EPS) and $3.23 billion in revenue. The consensus estimates from Thomson Reuters are calling…
Novavax Announces Restructuring Along With Mixed Q3 Earnings
Novavax, Inc. (NASDAQ: NVAX) reported third-quarter financial results after markets closed on Wednesday. The company said that it had a net loss of $0.24 per share and $3.2 million in revenue, versus consensus estimates…
SEC Charges Movie Producer With Defrauding Hedge Fund Investors
The U.S. Securities and Exchange Commission (SEC) recently charged a former movie producer and self-proclaimed private equity executive with defrauding investors in hedge funds and using the money he stole to support his extravagant…
What a Trump Presidency Could Mean for Alibaba
Alibaba shares fell in Wednesday’s regular trading session, after it was announced that Trump won the U.S. presidency.
Sucampo Pharmaceuticals Rises on Solid Earnings Beat and Guidance
Sucampo Pharmaceuticals reported better-than-expected third-quarter financial results before the markets opened on Wednesday.
What to Expect From Mylan Earnings
EpiPen maker Mylan is scheduled to report its third-quarter financial results after the markets close on Wednesday.
Ionis Pharmaceuticals Rises Despite Missing Earnings
Ionis Pharmaceuticals reported disappointing third-quarter financial results before the markets opened on Wednesday.
9 Big Losers From Hillary Clinton Not Winning the White House
Many brokerage firms and economists said that a Trump victory would be awful for stocks, with an immediate correction. 24/7 Wall St. has identified several immediate losers.
Why Arrowhead Pharmaceuticals Shares Are Sliding
Arrowhead Pharmaceuticals shares plummeted early on Wednesday after the company gave an update on its hepatitis B virus treatment.
Vivint Solar Posts Mixed Q3 Results
Vivint Solar, Inc. (NYSE: VSLR) reported third-quarter financial results after markets closed on Tuesday. The company said that it had a net loss of $0.36 per share and $41.3 million in revenue. The consensus estimates…
BioScrip Falls on Weak Earnings and Guidance
BioScrip, Inc. (NASDAQ: BIOS) reported third-quarter financial results before the markets opened on Tuesday. The company said that it had a net loss of $0.09 per share and $224.5 million in revenues. There were…
Why Oppenheimer Now Prefers CenturyLink Over AT&T
Investors look through various research reports to find new value in many different forms. In this case one key analyst firm is making a large shift and announcing its change in preference.
What to Look for in Novavax Earnings
Novavax is scheduled to report its third-quarter financial results before the markets open on Wednesday.
Why Hertz Shares Are Getting Halved
Shares of Hertz Global were cut in half on Tuesday after the company missed earnings in its most recent report.
Acadia Pharmaceuticals Jumps on Incredible Earnings
After Acadia Pharmaceuticals released its third-quarter earnings report after the markets closed on Monday, shares rose sharply Tuesday morning.
Depomed Tumbles on Missed Earnings
After Depomed reported disappointing third-quarter financial results after the markets closed on Monday, shares tumbled early Tuesday.
What to Expect From Vivint Solar Earnings
Vivint Solar is scheduled to report its third-quarter financial results after the markets close on Tuesday.
Why Valeant Earnings Have Brought a New Multiyear Low for Investors
Over the past month, Valeant Pharmaceuticals sank to just above its 52-week low, but it appears that it has now been pushed over the edge with this most recent earnings report.
Priceline Rises on Earnings Beat
The Priceline Group Inc. (NASDAQ: PCLN) reported third-quarter financial results after markets closed on Monday. The company posted $31.18 in earnings per share (EPS) and $3.69 billion in revenue. There were consensus estimates from…